StonvexLoading…
StonvexStonvexStonvexCore line items from TROW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.31B | $7.09B | $6.46B | $6.49B |
Operating Income | $2.19B | $2.33B | $1.99B | $2.37B |
Net Income | $2.09B | $2.10B | $1.79B | $1.56B |
EPS (Diluted) | $9.24 | $9.15 | $7.76 | $6.70 |
Total Assets | $14.34B | $13.47B | $12.28B | $11.64B |
Total Liabilities | $2.29B | $2.02B | $1.99B | $1.96B |
Cash & Equivalents | $3.38B | $2.65B | $2.07B | $1.76B |
Free Cash Flow OCF − CapEx | $1.48B | $1.26B | $911.20M | $2.12B |
Shares Outstanding | 218.56M | 222.97M | 224.80M | 227.10M |